Option Care Selected as a Preferred Provider of Home Infusion IG Therapy for AmeriHealth members

Effective March 1, 2016, Option Care Enterprises, Inc. will be a preferred provider of intravenous and subcutaneous immunoglobulin (IVIG/SCIG) drugs provided in the home* for members covered by AmeriHealth.

As one of the nation’s largest providers of home and alternate treatment site infusion services, Option Care’s specially trained nurses and pharmacists provide high-quality, high-touch clinical support to patients treated for complex conditions, including those receiving IG. Option Care IG patients report very high levels of satisfaction – 98 percent – with Option Care’s in-home visits and ongoing support calls to help them manage their conditions.[i]

IG therapy is prescribed to patients with immune system-related conditions, including primary immunodeficiency disorders (the body’s immune system doesn’t function properly), autoimmune disorders (the body attacks itself) and other conditions that benefit from the treatment. IG therapy is delivered one of two ways: IVIG is infused through a vein, and SCIG is delivered into the fatty tissue just below the skin. Including IVIG and SCIG, Option Care manages more than 55,000 IG infusions each year.ii

In a recent first-of-its kind study, Option Care home IG patients, who receive a high level of clinical oversight, had better outcomes when compared to a large national database of patients who received IG therapy in other settings.

Option Care provides access to all IG products, and its more than 1,700 clinicians, including nurses and pharmacists specially trained in IVIG/SCIG, provide high-quality care, including individualized patient care plans, clinical monitoring of each infusion and comprehensive patient and caregiver education.

[i] Option Care Enterprises, Inc. Data on file 2016.

[i][i] Orange J, Kirkham H, Ayer G, et al. Improved clinical outcomes for patients receiving immunoglobulin therapy through specialty pharmacy or home infusion services. Paper presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2015 Annual Scientific Meeting: Nov 5-9, 2015; San Antonio.

*Members can continue to receive IVIG/SCIG from home infusion vendors currently owned by a hospital or health system participating in the AmeriHealth provider network.